BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee SH, Kim JW, Park SJ, Heo JY, Paik WH, Bae WK, Kim NH, Kim KA, Lee JS. Obstructive ileus caused by phlebosclerotic colitis. Intest Res 2016;14:369-74. [PMID: 27799889 DOI: 10.5217/ir.2016.14.4.369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Shimada Y, Fujimoto M, Nogami T, Watari H. Adverse Events Associated with Ethical Kampo Formulations: Analysis of the Domestic Adverse-Event Data Reports of the Ministry of Health, Labor, and Welfare in Japan. Evid Based Complement Alternat Med 2019;2019:1643804. [PMID: 31118950 DOI: 10.1155/2019/1643804] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
2 Minh ND, Hung ND, Huyen PT, Van Anh NT, Lanh NS, Anh PQ, Duc NM. Phlebosclerotic colitis with long-term herbal medicine use. Radiology Case Reports 2022;17:1696-701. [DOI: 10.1016/j.radcr.2022.02.069] [Reference Citation Analysis]
3 Klein S, Buchner D, Chang DH, Büttner R, Drebber U, Fries JWU. Exclusive Phlebosclerosis of Submucosal Veins Leading to Ischemic Necrosis and Perforation of the Large Bowel: First European Case. Case Rep Gastroenterol 2018;12:137-42. [PMID: 29805356 DOI: 10.1159/000488195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Chen W, Zhu H, Chen H, Shan G, Xu G, Chen L, Dong F. Phlebosclerotic colitis: Our clinical experience of 25 patients in China. Medicine (Baltimore). 2018;97:e12824. [PMID: 30412073 DOI: 10.1097/md.0000000000012824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]